[Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
D000276:Adjuvants, Immunologic; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine
Inmunoterapia con B.C.G. como coadyuvante en el manejo de pacientes con melanoma maligno.